Zaroxolyn

Zaroxolyn is a brand name of metolazone, approved by the FDA in the following formulation(s):

ZAROXOLYN (metolazone - tablet; oral)

• 
  Manufacturer: UCB INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 10MG ^[RLD][AB], 2.5MG ^[AB], 5MG ^[RLD][AB]

Has a generic version of Zaroxolyn been approved?

Yes. The following products are equivalent to Zaroxolyn:

metolazone tablet; oral

• 
  Manufacturer: MYLAN
  
  Approval date: December 23, 2003
  
  Strength(s): 2.5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: October 19, 2004
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: December 19, 2003
  
  Strength(s): 10MG ^[AB], 2.5MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: December 24, 2003
  
  Strength(s): 10MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: January 6, 2004
  
  Strength(s): 2.5MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: March 1, 2004
  
  Strength(s): 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zaroxolyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zaroxolyn.

See also...

• Zaroxolyn Consumer Information (Wolters Kluwer)
• Zaroxolyn Consumer Information (Cerner Multum)
• Zaroxolyn Advanced Consumer Information (Micromedex)
• Zaroxolyn AHFS DI Monographs (ASHP)
• Metolazone Consumer Information (Wolters Kluwer)
• Metolazone Consumer Information (Cerner Multum)
• Metolazone Advanced Consumer Information (Micromedex)
• Metolazone AHFS DI Monographs (ASHP)